TY - JOUR
T1 - The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy
AU - Bieniek, Kevin F.
AU - Cairns, Nigel J.
AU - Crary, John F.
AU - Dickson, Dennis W.
AU - Folkerth, Rebecca D.
AU - Keene, C. Dirk
AU - Litvan, Irene
AU - Perl, Daniel P.
AU - Stein, Thor D.
AU - Vonsattel, Jean Paul
AU - Stewart, William
AU - Dams-O'connor, Kristen
AU - Gordon, Wayne A.
AU - Tripodis, Yorghos
AU - Alvarez, Victor E.
AU - Mez, Jesse
AU - Alosco, Michael L.
AU - Mckee, Ann C.
AU - Babcock, Debra
AU - Bellgowan, Patrick
AU - Crane, Paul
AU - Edlow, Brian
AU - Huber, Bertrand Russ
AU - Kiernan, Patrick
AU - Koroshetz, Walter
N1 - Funding Information:
This study was supported by the National Institute of Neurological Disorders and Stroke (1U01NS086659-01, 1U01NS086625-01, R01NS078337, R56NS078337, R01NS095252), Department of Defense (W81XWH-13-2-0064, W81XWH-14-1-0399), Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the National Institute of Aging (1R01AG061028-01), the National Institute of Aging Boston University Alzheimer’s Disease Center (P30AG13846; supplement 0572063345-5), Department of Defense Peer Reviewed Alzheimer’s Research Program (DoD-PRARP #13267017), the National Institute of Aging Boston University Framingham Heart Study (R01AG1649), the National Operating Committee on Standards for Athletic Equipment and the Concussion Legacy Foundation. This study was also supported by unrestricted gifts from the Andlinger Foundation, the World Wrestling Entertainment and the National Football League. This study was also supported by grants P50 AG05681 and P01 AG03991 from the National Institute on Aging (NJC).
Funding Information:
In March 2013, the National Institutes of Health (NIH), supported by the Foundation for NIH’s Sports Health Research Program with funding from the National Football League (NFL), launched a major effort to define the neuropathologic characteristics of CTE. The first NINDS/NIBIB consensus panel met in February 2015 to blindly evaluate 25 cases of various tauopathies, including CTE, AD, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Guamanian parkinsonism dementia complex (GPDC), argyrophilic grain disease (AGD), and primary age-related tauopathy (PART) using the preliminary criteria proposed by McKee et al (). Eight neuropathologists, blinded to all clinical and demographic information, successfully identified CTE pathology amongst 25 cases of various tauopathies and determined that CTE was a distinct disease. The panel also defined a pathognomonic lesion of CTE as “an accumulation of abnormal hyperphosphorylated tau (p-tau) in neurons and astroglia distributed around small blood vessels at the depths of cortical sulci and in an irregular pattern.” In addition, the group defined supportive but nonspecific p-tau-immunoreactive features of CTE (). Since their publication, the NINDS/NIBIB criteria for the neuropathological diagnosis of CTE have been widely adopted and used in neuropathological evaluation of CTE in diverse research brain banks and autopsy cohorts (, , ).
Publisher Copyright:
© 2021 Oxford University Press. All rights reserved.
PY - 2021/3/1
Y1 - 2021/3/1
N2 - Chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder associated with exposure to head trauma. In 2015, a panel of neuropathologists funded by the NINDS/NIBIB defined preliminary consensus neuropathological criteria for CTE, including the pathognomonic lesion of CTE as "an accumulation of abnormal hyperphosphorylated tau (p-tau) in neurons and astroglia distributed around small blood vessels at the depths of cortical sulci and in an irregular pattern," based on review of 25 tauopathy cases. In 2016, the consensus panel met again to review and refine the preliminary criteria, with consideration around the minimum threshold for diagnosis and the reproducibility of a proposed pathological staging scheme. Eight neuropathologists evaluated 27 cases of tauopathies (17 CTE cases), blinded to clinical and demographic information. Generalized estimating equation analyses showed a statistically significant association between the raters and CTE diagnosis for both the blinded (OR = 72.11, 95% CI = 19.5-267.0) and unblinded rounds (OR = 256.91, 95% CI = 63.6-1558.6). Based on the challenges in assigning CTE stage, the panel proposed a working protocol including a minimum threshold for CTE diagnosis and an algorithm for the assessment of CTE severity as "Low CTE" or "High CTE" for use in future clinical, pathological, and molecular studies.
AB - Chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder associated with exposure to head trauma. In 2015, a panel of neuropathologists funded by the NINDS/NIBIB defined preliminary consensus neuropathological criteria for CTE, including the pathognomonic lesion of CTE as "an accumulation of abnormal hyperphosphorylated tau (p-tau) in neurons and astroglia distributed around small blood vessels at the depths of cortical sulci and in an irregular pattern," based on review of 25 tauopathy cases. In 2016, the consensus panel met again to review and refine the preliminary criteria, with consideration around the minimum threshold for diagnosis and the reproducibility of a proposed pathological staging scheme. Eight neuropathologists evaluated 27 cases of tauopathies (17 CTE cases), blinded to clinical and demographic information. Generalized estimating equation analyses showed a statistically significant association between the raters and CTE diagnosis for both the blinded (OR = 72.11, 95% CI = 19.5-267.0) and unblinded rounds (OR = 256.91, 95% CI = 63.6-1558.6). Based on the challenges in assigning CTE stage, the panel proposed a working protocol including a minimum threshold for CTE diagnosis and an algorithm for the assessment of CTE severity as "Low CTE" or "High CTE" for use in future clinical, pathological, and molecular studies.
KW - Brain trauma
KW - Chronic traumatic encephalopathy
KW - Neurodegenerative disorders
KW - Tauopathy
KW - Traumatic brain injury
UR - http://www.scopus.com/inward/record.url?scp=85103306629&partnerID=8YFLogxK
U2 - 10.1093/jnen/nlab001
DO - 10.1093/jnen/nlab001
M3 - Article
C2 - 33611507
AN - SCOPUS:85103306629
SN - 0022-3069
VL - 80
SP - 210
EP - 219
JO - Journal of Neuropathology and Experimental Neurology
JF - Journal of Neuropathology and Experimental Neurology
IS - 3
ER -